Extended Delay to Treatment for Stage III-IV Non–Small-Cell Lung Cancer and Survival: Balancing Risks During the COVID-19 Pandemic

BACKGROUND: Due to the coronavirus disease 2019 (COVID-19) pandemic, patients may encounter lung cancer care delays. Here, we sought to examine the impact of extended treatment delay for stage III-IV non–small-cell lung cancer on patient survival. MATERIALS AND METHODS: Using National Lung Screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayne, Nicholas R., Bajaj, Simar S., Powell, Joseph, Elser, Holly C., Civiello, Barbara S., Fintelmann, Florian J., Li, Xiao, Yang, Chi-Fu Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068243/
https://www.ncbi.nlm.nih.gov/pubmed/35660355
http://dx.doi.org/10.1016/j.cllc.2022.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068243/
https://www.ncbi.nlm.nih.gov/pubmed/35660355
http://dx.doi.org/10.1016/j.cllc.2022.05.001

Ejemplares similares